Edwards Lifesciences (EW) Cash from Investing Activities Growth (5y) (2014 - 2026)
Edwards Lifesciences (EW) Cash from Investing Activities Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.94 Bn | 194.34 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.49 Bn | 4.50 Bn |
| 3 | Medtronic | 120.01 Bn | 110.79 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.40 Bn | 1.35 Bn |
| 6 | Dexcom | 34.63 Bn | 32.68 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.02 Bn | 31.91 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.13% |
| Mar 31, 2026 | -13.30% |
| Dec 31, 2025 | 5.27% |
| Sep 30, 2025 | -27.63% |
| Jun 30, 2025 | -75.97% |
| Mar 31, 2025 | 21.37% |
| Dec 31, 2024 | -5.31% |
| Sep 30, 2024 | 192.67% |
| Jun 30, 2024 | 27.83% |
| Mar 31, 2024 | 26.78% |
| Dec 31, 2023 | 19.86% |
| Sep 30, 2023 | 18.64% |
| Jun 30, 2023 | -7.72% |
| Mar 31, 2023 | -70.41% |
| Dec 31, 2022 | 13.95% |
| Sep 30, 2022 | 0.78% |
| Jun 30, 2022 | 17.11% |
| Mar 31, 2022 | 8.70% |
| Dec 31, 2021 | -69.63% |
| Sep 30, 2021 | -150.57% |